[EN] COMPOUNDS FOR INHIBITING CELL PROLIFERATION IN EGFR-DRIVEN CANCERS<br/>[FR] COMPOSÉS POUR INHIBER LA PROLIFÉRATION CELLULAIRE DANS LES CANCERS INDUITS PAR L'EGFR
申请人:ARIAD PHARMA INC
公开号:WO2013169401A1
公开(公告)日:2013-11-14
The invention features compounds, pharmaceutical compositions and methods for treating patients who have an EGFR-driven cancer of Formula (I), wherein the variables are as defined herein.
Manganese-Catalyzed Directed Methylation of C(sp<sup>2</sup>)–H Bonds at 25 °C with High Catalytic Turnover
作者:Takenari Sato、Takumi Yoshida、Hamad H. Al Mamari、Laurean Ilies、Eiichi Nakamura
DOI:10.1021/acs.orglett.7b02778
日期:2017.10.6
scope, using MeMgBr, a catalyticamount of MnCl2·2LiCl, and an organic dihalide oxidant. The reaction features ambient temperature, low catalyst loading, typically 1%, high catalytic turnover reaching 5.9 × 103, and no need for an extraneous ligand and illustrates a unique catalytic use of simple manganese salts for C–H activation, which so far has relied on catalysis by manganese carbonyls.
PTERIDINE KETONE DERIVATIVE AND APPLICATIONS THEREOF AS EGFR, BLK, AND FLT3 INHIBITOR
申请人:EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
公开号:US20150126508A1
公开(公告)日:2015-05-07
Provided are a pteridine ketone derivative used as an EGFR, BLK, and FLT3 inhibitor and applications thereof. Specifically, provided are a compound of the following formula I, a pharmaceutical composition containing the compound of the formula I, and use of compound in preparing medicine for treating diseases mediated by EGFR, BLK, or FLT3 or inhibiting EGFR, BLK, and FLT3.
Reaction of organomagnesium compounds with derivatives of cyclohexene-1-carboxylic acid
作者:J. Klein
DOI:10.1016/s0040-4020(01)93234-x
日期:1964.1
the amide (IIf) undergo both 1,2; and 1,4-additions. The unsubstituted amide (IId) gives predominantly 1,2-addition. The ketone (IVg) unlike ketones with one alkyl group undergoes 1,4-addition. The reaction of other Grignard reagents as well as phenyllithium with the same conjugated derivatives was also studied. Factors that determine 1,2 and 1,4-addition are discussed.
with vinylene carbonate for the synthesis of isoquinolinones and pyridinones has been developed. This protocol employing inexpensive Co(III) as the catalyst tolerated diverse functional groups and substitution patterns, affording the target products with good to excellent yields. The synthetic utility of this transformation was demonstrated by a three-step synthesis of gusanlung D, 8-oxopseudopalmatine